Cargando…
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Interleukin-6 (IL-6) is a multi-tasking cytokine that represents high activity in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and cancer. High concentration of this pleiotropic cytokine accounts for hyperinflammation and cytokine storm, and is related to multi-organ fa...
Autores principales: | Majidpoor, Jamal, Mortezaee, Keywan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585600/ https://www.ncbi.nlm.nih.gov/pubmed/34781146 http://dx.doi.org/10.1016/j.biopha.2021.112419 |
Ejemplares similares
-
Cellular immune states in SARS-CoV-2-induced disease
por: Mortezaee, Keywan, et al.
Publicado: (2022) -
CD8(+) T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives
por: Mortezaee, Keywan, et al.
Publicado: (2022) -
Checkpoint inhibitor/interleukin‐based combination therapy of cancer
por: Mortezaee, Keywan, et al.
Publicado: (2022) -
(Im)maturity in Tumor Ecosystem
por: Mortezaee, Keywan, et al.
Publicado: (2022) -
Transforming growth factor‐β signalling in tumour resistance to the anti‐PD‐(L)1 therapy: Updated
por: Mortezaee, Keywan, et al.
Publicado: (2023)